Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

European Journal of Immunology

Volumn 30, Issue 12, 2000, Pages 3689-3698

  Van Pinxteren, Laurens A H ^a   Cassidy, Joseph P ^a   Smedegaard, Birgitte H C ^a   Agger, Else M ^a   Andersen, Peter ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

CD8 T cell; Latency; Tuberculosis

Indexed keywords

ANTIMYCOBACTERIAL AGENT; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENCE; IMMUNOSTIMULATION; INFECTION CONTROL; LATENT PERIOD; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

ACUTE DISEASE; ANIMALS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; INTERFERON TYPE II; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; TUBERCULOSIS;

EID: 0034529550     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4     Document Type: Article

References (54)

1. Development of new vaccines for tuberculosis. Recommendations of the Advisory Council for the eliminating of tuberculosis (ACET)
2. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: Recrudescence of residuals of the primary infection or exogenous reinfection
3. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods
4. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods
5. The molecular epidemiology of tuberculosis in New York City: The importance of nosocomial transmission and laboratory error
6. The clinical spectrum of primary tuberculosis in adults confusion with reinfection in the pathogenesis of chronic tuberculosis
7. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
8. Disseminated tuberculosis in interferon gamma gene-disrupted mice
9. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
10. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
11. Immunity to mycobacteria with emphasis on tuberculosis: Implication for rational design of an effective tuberculosis vaccine
12. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
13. The new tuberculosis
14. Tuberculosis in patients with human immunodeficiency virus infection
15. The pathogenesis of pulmonary tuberculosis among older persons
16. Mycobacterium tuberculosis
17. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the micribial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy
18. A mouse model of the recrudescence of latent tuberculosis in the elderly
19. Effects of aminoguanidine on latent murine tuberculosis
20. A mouse model for latent tuberculosis
21. Reactivation of latent tuberculosis variations on the Cornell murine model
22. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculosis infection to the latent state by the administration of pyrazinamide and companion drug
23. Turnover of naive- and memory-phenotype T cells
24. + T cell response and memory
25. + T cells activated in a graft-versus-host reaction
26. + T cells with a type 1 cytokine profile
27. Naive effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals
28. +, T cells in lungs following aerosol infection with Mycobacterium tuberculosis
29. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice
30. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
31. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knockout mice: Contribution of CD4 and CD8 T cells to acquired resistance
32. + T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host
33. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii
34. Opportunistic infections and retrovirus-induced immunodeficiency: Studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses
35. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens
36. + T lymphocytes in intracellular microbial infections
37. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice
38. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms
39. Differential effects of cytolytic T cell subsets on intracellular infection
40. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
41. + T cells requires the production of gamma interferon
42. Stationary phase-associated protein expression in Mycobacterium tuberculosis: Function of the mycobacterial alpha-crystallin homolog
43. Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis
44. Mycobacterial stationary phase induced by low oxygen tension: Cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog
45. Therapy of tuberculosis in mice by DNA vaccination
46. Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode
47. Evaluation of new vaccines in the mouse guinea pig model of tuberculosis
48. Naked DNA vaccination
49. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins
50. Tuberculosis: The role of the immune response
51. T cell proliferative response to antigens secreted by Mycobacterium tuberculosis
52. Proteins released from Mycobacterium tuberculosis during growth
53. B cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
54. ESAT-6 subunit vaccination against Mycobacterium tuberculosis